Circular RNA circ_0089153 acts as a competing endogenous RNA to regulate colorectal cancer development by the miR-198/SUMO-specific peptidase 1 (SENP1) axis

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Brody H. Colorectal cancer. Nature. 2015;521:S1.
   PubMed Web of Science ®Google Scholar
• Modest DP, Pant S, Sartore-Bianchi A. Treatment sequencing in metastatic colorectal cancer. Eur J Cancer. 2019;109:70–83.
   PubMed Web of Science ®Google Scholar
• Strubberg AM, Madison BB. MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications. Dis Model Mech. 2017;10:197–214.
   PubMed Web of Science ®Google Scholar
• Gmerek L, Martyniak K, Horbacka K, et al. MicroRNA regulation in colorectal cancer tissue and serum. PLoS One. 2019;14:e0222013.
   PubMed Web of Science ®Google Scholar
• Naeli P, Pourhanifeh MH, Karimzadeh MR, et al. Circular RNAs and gastrointestinal cancers: epigenetic regulators with a prognostic and therapeutic role. Crit Rev Oncol Hematol. 2020;145:102854.
   PubMed Web of Science ®Google Scholar
• Xu H, Wang C, Song H, et al. RNA-Seq profiling of circular RNAs in human colorectal cancer liver metastasis and the potential biomarkers. Mol Cancer. 2019;18:8.
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20:675–691.
   PubMed Web of Science ®Google Scholar
• Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505:344–352.
   PubMed Web of Science ®Google Scholar
• Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18:5–18.
   PubMed Web of Science ®Google Scholar
• Gu Q, Hou W, Shi L, et al. Circular RNA ZNF609 functions as a competing endogenous RNA in regulating E2F transcription factor 6 through competitively binding to microRNA-197-3p to promote the progression of cervical cancer progression. Bioengineered. 2021;12:927–936.
   PubMed Web of Science ®Google Scholar
• Chen H, Gu B, Zhao X, et al. Circular RNA hsa_circ_0007364 increases cervical cancer progression through activating methionine adenosyltransferase II alpha (MAT2A) expression by restraining microRNA-101-5p. Bioengineered. 2020;11:1269–1279.
   PubMed Web of Science ®Google Scholar
• Shuwen H, Qing Z, Yan Z, et al. Competitive endogenous RNA in colorectal cancer: a systematic review. Gene. 2018;645:157–162.
   PubMed Web of Science ®Google Scholar
• Xie L, Pan Z. Circular RNA circ_0000467 regulates colorectal cancer development via miR-382-5p/EN2 axis. Bioengineered. 2021;12:886–897.
   PubMed Web of Science ®Google Scholar
• Liu K, Mou Y, Shi X, et al. Circular RNA 100146 promotes colorectal cancer progression by the MicroRNA 149/HMGA2 axis. Mol Cell Biol. 2021;41:e00445–20.
   PubMed Web of Science ®Google Scholar
• Fang G, Ye BL, Hu BR, et al. CircRNA_100290 promotes colorectal cancer progression through miR-516b-induced downregulation of FZD4 expression and Wnt/β-catenin signaling. Biochem Biophys Res Commun. 2018;504:184–189.
   PubMed Web of Science ®Google Scholar
• Li X, Wang J, Zhang C, et al. Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7. J Pathol. 2018;246:166–179.
   PubMed Web of Science ®Google Scholar
• Chen P, Yao Y, Yang N, et al. Circular RNA circCTNNA1 promotes colorectal cancer progression by sponging miR-149-5p and regulating FOXM1 expression. Cell Death Dis. 2020;11:557.
   PubMed Web of Science ®Google Scholar
• Sun M, Song H, Wang S, et al. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer. J Hematol Oncol. 2017;10:79.
   PubMed Web of Science ®Google Scholar
• Huang L, Zhang Y, Li Z, et al. MiR-4319 suppresses colorectal cancer progression by targeting ABTB1. United European Gastroenterol J. 2019;7:517–528.
   PubMed Web of Science ®Google Scholar
• Iseki Y, Shibutani M, Maeda K, et al. MicroRNA-96 promotes tumor invasion in colorectal cancer via RECK. Anticancer Res. 2018;38:2031–2035.
   PubMed Web of Science ®Google Scholar
• Iida M, Hazama S, Tsunedomi R, et al. Overexpression of miR‑221 and miR‑222 in the cancer stroma is associated with malignant potential in colorectal cancer. Oncol Rep. 2018;40:1621–1631.
   PubMed Web of Science ®Google Scholar
• Wang M, Wang J, Kong X, et al. MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8. Sci Rep. 2014;4:6145.
   PubMed Web of Science ®Google Scholar
• Li LX, Lam IH, Liang FF, et al. MiR-198 affects the proliferation and apoptosis of colorectal cancer through regulation of ADAM28/JAK-STAT signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23:1487–1493.
   PubMed Web of Science ®Google Scholar
• Dudekula DB, Panda AC, Grammatikakis I, et al. CircInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2016;13:34–42.
   PubMed Web of Science ®Google Scholar
• Mirecka A, Morawiec Z, Wozniak K. Genetic polymorphism of SUMO-specific cysteine proteases - SENP1 and SENP2 in breast cancer. Pathol Oncol Res. 2016;22:817–823.
   PubMed Web of Science ®Google Scholar
• Ma C, Wu B, Huang X, et al. SUMO-specific protease 1 regulates pancreatic cancer cell proliferation and invasion by targeting MMP-9. Tumour Biol. 2014;35:12729–12735.
   PubMedGoogle Scholar
• Zhang X, Wang H, Wang H, et al. SUMO-specific cysteine protease 1 promotes epithelial mesenchymal transition of prostate cancer cells via regulating SMAD4 deSUMOylation. Int J Mol Sci. 2017;18:808.
   PubMed Web of Science ®Google Scholar
• Xu Y, Li J, Zuo Y, et al. SUMO-specific protease 1 regulates the in vitro and in vivo growth of colon cancer cells with the upregulated expression of CDK inhibitors. Cancer Lett. 2011;309:78–84.
   PubMed Web of Science ®Google Scholar
• Zhou M, Bian Z, Liu B, et al. Long noncoding RNA MCM3AP-AS1 enhances cell proliferation and metastasis in colorectal cancer by regulating miR-193a-5p/SENP1. Cancer Med. 2021;10:2470–2481.
   PubMed Web of Science ®Google Scholar
• Viswanathan SR, Powers JT, Einhorn W, et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet. 2009;41:843–848.
   PubMed Web of Science ®Google Scholar
• Jaca A, Govender P, Locketz M, et al. The role of miRNA-21 and epithelial mesenchymal transition (EMT) process in colorectal cancer. J Clin Pathol. 2017;70:331–356.
   PubMed Web of Science ®Google Scholar
• Buranasin P, Mizutani K, Iwasaki K, et al. High glucose-induced oxidative stress impairs proliferation and migration of human gingival fibroblasts. PLoS One. 2018;13:e0201855.
   PubMed Web of Science ®Google Scholar
• Bahmad HF, Cheaito K, Chalhoub RM, et al. Sphere-formation assay: three-dimensional in vitro culturing of prostate cancer stem/progenitor sphere-forming cells. Front Oncol. 2018;8:347.
   PubMed Web of Science ®Google Scholar
• Gentile MT, Pastorino O, Bifulco M, et al. HUVEC tube-formation assay to evaluate the impact of natural products on angiogenesis. J Vis Exp. 2019;24:148.
   Google Scholar
• Liu X, Zhang Z, Ruan J, et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016;535:153–158.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Lu S, Li T, et al. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway. J Exp Clin Cancer Res. 2019;38:173.
   PubMed Web of Science ®Google Scholar
• Iwakawa HO, Tomari Y. The functions of MicroRNAs: mRNA decay and translational repression. Trends Cell Biol. 2015;25:651–665.
   PubMed Web of Science ®Google Scholar
• Karreth FA, Pandolfi PP. ceRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov. 2013;3:1113–1121.
   PubMed Web of Science ®Google Scholar
• Liu J, Qiao X, Liu J, et al. Identification of circ_0089153/miR-608/EGFR p53 axis in ameloblastoma via MAPK signaling pathway. Oral Dis. 2021.
   Web of Science ®Google Scholar
• Hassani B, Mollanoori H, Pouresmaeili F, et al. Constructing MRNA, miRNA, circRNA and lncRNA regulatory network by analysis of microarray data in breast cancer. 2021.
   Google Scholar
• Li X, Tian Y, Hu Y, et al. CircNUP214 sponges miR-145 to promote the expression of ZEB2 in thyroid cancer cells. Biochem Biophys Res Commun. 2018;507:168–172.
   PubMed Web of Science ®Google Scholar
• De Francesco EM, Sotgia F, Lisanti MP. Cancer stem cells (CSCs): metabolic strategies for their identification and eradication. Biochem J. 2018;475:1611–1634.
   PubMed Web of Science ®Google Scholar
• Munro MJ, Wickremesekera SK, Peng L, et al. Cancer stem cells in colorectal cancer: a review. J Clin Pathol. 2018;71:110–116.
   PubMed Web of Science ®Google Scholar
• Leone P, Buonavoglia A, Fasano R, et al. Insights into the regulation of tumor angiogenesis by Micro-RNAs. J Clin Med. 2019;8:2030.
   PubMed Web of Science ®Google Scholar
• Li T, Kang G, Wang T, et al. Tumor angiogenesis and anti-angiogenic gene therapy for cancer. Oncol Lett. 2018;16:687–702.
   PubMed Web of Science ®Google Scholar
• Liu W, Zhao J, Jin M, et al. circRAPGEF5 contributes to papillary thyroid proliferation and metastatis by regulation miR-198/FGFR1. Mol Ther Nucleic Acids. 2019;14:609–616.
   PubMedGoogle Scholar
• Ray J, Hoey C, Huang X, et al. MicroRNA198 suppresses prostate tumorigenesis by targeting MIB1. Oncol Rep. 2019;42:1047–1056.
   PubMed Web of Science ®Google Scholar
• Wu S, Zhang G, Li P, et al. miR-198 targets SHMT1 to inhibit cell proliferation and enhance cell apoptosis in lung adenocarcinoma. Tumour Biol. 2016;37:5193–5202.
   PubMedGoogle Scholar
• Wang G, Li Y, Zhu H, et al. Circ-PRKDC facilitates the progression of colorectal cancer through miR-198/DDR1 regulatory axis. Cancer Manag Res. 2020;12:12853–12865.
   PubMed Web of Science ®Google Scholar
• Zhou GQ, Han F, Shi ZL, et al. miR-133a-3p targets SUMO-specific protease 1 to inhibit cell proliferation and cell cycle progress in colorectal cancer. Oncol Res. 2018;26:795–800.
   PubMed Web of Science ®Google Scholar